SAREPTA THERAPEUTICS INC

CUSIP: 803607AB6 Class: DBCV 1.500%11/1

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 1,000,000 Value ($000) $1,710 Avg Close — Range —
Q2 2024
Shares 1,000,000 Value ($000) $2,159 Avg Close — Range —
Q1 2024
Shares 1,000,000 Value ($000) $1,787 Avg Close — Range —
Q4 2023
Shares 1,000,000 Value ($000) $1,410 Avg Close — Range —
Q3 2023
Shares 1,000,000 Value ($000) $1,766 Avg Close — Range —
Q2 2023
Shares 1,000,000 Value ($000) $1,696 Avg Close — Range —
Q1 2023
Shares 2,051,000 Value ($000) $3,989 Avg Close — Range —
Q4 2022
Shares 2,051,000 Value ($000) $3,832 Avg Close — Range —
Q3 2022
Shares 3,831,000 Value ($000) $6,522 Avg Close — Range —
Q2 2022
Shares 3,156,000 Value ($000) $3,980 Avg Close — Range —
Q1 2022
Shares 3,156,000 Value ($000) $4,163 Avg Close — Range —
Q4 2021
Shares 3,218,000 Value ($000) $4,726 Avg Close — Range —
Q3 2021
Shares 3,148,000 Value ($000) $4,666 Avg Close — Range —
Q2 2021
Shares 3,469,000 Value ($000) $4,584 Avg Close — Range —
Q1 2021
Shares 3,542,000 Value ($000) $4,649 Avg Close — Range —
Q4 2020
Shares 3,242,000 Value ($000) $7,951 Avg Close — Range —
Q3 2020
Shares 3,242,000 Value ($000) $6,705 Avg Close — Range —
Q2 2020
Shares 3,335,000 Value ($000) $7,663 Avg Close — Range —